Aureum
About AureumDx
Aureum Diagnostics develops low cost and easy to use electrochemistry based platforms capable of delivering category defining performance across both the biosafety and point of use markets. Our flexible platform and approach to technology development means we are interested in detecting a range of biological and chemical analytes, including but not limited to: nucleic acids, proteins, small molecules and ionic species.
Vision
To transform global access to high performance electrochemical diagnostics.
Mission
To develop and commercialise exquisitely sensitive, single step, low-cost electrochemical biosensor detection platforms that leapfrog current and upcoming competitor technologies.
Sustainability
Championing a sustainable, low-carbon approach that not only pioneers technological advancements but also guarantees that diagnostics are available to all.
Our Foundation
Origins: Founded in 2021 with seed funding of £3.5m AureumDX is led by an expert executive team whose skills are complemented by a highly experienced team of industry expert advisors.
The company is located Maxim Park, Euro central near Glasgow in Scotland.”
Core Values & Operating Principles
Sustainability: Championing a sustainable, low-carbon approach that not only pioneers technological advancements but also guarantees that diagnostics are available to all.
Technology at the Forefront
Key Features: AureumDX’s biosensor platforms are radically differentiated, low-cost, high-performance electrochemical diagnostic platforms for the rapid, simple, and reliable detection of biological targets biomarkers. The unique electrochemical biosensor platforms have been designed to deliver market-leading measurement sensitivity while ensuring unrivaled product simplicity and affordability.
Sustainability
The Road Ahead
Strategic Growth Path: AureumDx’s is focused on the development of next generation biosensing platforms for partners in the high value decentralised Point-of-Care Medical Diagnostics and Biosafety markets.
